MedPage Today September 28, 2024
Joyce Frieden

— “People will continue to have ample, affordable choices”

Average premiums and benefits for Medicare Advantage (MA) and Medicare Part D drug plans will remain stable in 2025, CMS officials said Friday.

“Bottom line: average premiums, benefits and plan choices for Medicare Advantage and the Medicare Part D prescription drug program will remain stable in 2025 just as they were in 2024,” Meena Seshamani, MD, PhD, director of the CMS Center for Medicare, said on a call with reporters. “Average premiums are projected to decline in both the Medicare Advantage and Part D program from 2024 to 2025.”

“CMS has taken significant steps over the last few years — improved payment accuracy and improved protection for people with Medicare —...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Medicare Advantage, Patient / Consumer
Related Articles:
Increasing the Longevity of Accountability, Designing Cooperative Models, and Transferring Risk Across a Lifetime of Accountable Care
Primary care-centric ACOs generate better savings and better outcomes
State Health Insurance Assistance Program Provides Valuable Guidance to Medicare Beneficiaries, but Many Don’t Know It Exists
Report: Practices in Two-Sided Risk Drove Savings in Oncology Care Model
US News names top Medicare Advantage, Part D providers for 2025

Share This Article